SMZ1.STU Sino Biopharmaceutical Limited

Other Metals & Mining Stuttgart Exchange
- EUR
Market cap
-
P/E
27.4x
P/B
2.28x
ROE
7.6%
Dividend yield
4.55%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is SMZ1.STU undervalued?

Graham number

The Graham number of Sino Biopharmaceutical Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sino Biopharmaceutical Limited fundamental analysis

No fundamental analysis for Sino Biopharmaceutical Limited yet.

Sino Biopharmaceutical Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited, an investment holding company, researches and develops, produces, and sells Chinese and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in three segments: Chemical Medicines and Biopharmaceutical Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianding tablets, Tianqingganping enteric capsules, Ming…

Full company profile